News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer
Jun Gong/LinkedIn
Nov 19, 2024, 20:48

Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer

Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, shared a post on X about a recent paper by him and colleagues published in Taylor and Francis Research Insights’ Immunotherapy Journal.

“Just published! ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer following failure to clear MRD with adjuvant oxalipatin-based chemo.

Full access here.”

“ctDNA-guided adjuvant immunotherapy in colorectal cancer”

Authors: Nicholas Burley, Yurhee Lee, Louisa Liu, Alexandra Gangi, Yosef Nasseri, Katelyn Atkins, Karen Zaghiyan, Zuri Murrell, Arsen Osipov, Andrew Hendifar, Megan Hitchins, Jun Gong.

Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer

More posts featuring Jun Gong.

Alexandra Gangi Andrew Hendifar Arsen Osipov cancer Colon cancer immunotherapy Jun Gong Karen Zaghiyan Katelyn Atkins Louisa Liu Megan Hitchins Nicholas Burley OncoDaily Oncology Yosef Nasseri Yurhee Lee Zuri Murrell
Special Coverage
Insight
Nov 19, 2024, 20:48
Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer
Insight
Nov 19, 2024, 20:45
Pharmacogenomic predictors of common chemotherapy toxicities by Ivone U.S. Leong
Blog
Nov 19, 2024, 20:44
Dhan Chand: Expanding treatment options through innovative iNKT cell therapy combinations
Celebrities
Nov 19, 2024, 18:15
Rudy Giuliani and Prostate Cancer: How He Went Against, How He Survived, and More
Blog
Nov 19, 2024, 16:26
ERN PaedCan and Young SIOPE webinar on treatment toxicity in an adolescent with TLL
Blog
Nov 19, 2024, 15:21
Julie S. Torode: WHO launches new target product profiles for HPV screening for cervical cancer
Positive
Nov 19, 2024, 15:20
SIOG’s New Board of Directors for 2024-2026
Blog
Nov 19, 2024, 15:17
Miriam Mutebi: Is it time for you to get screened?
Blog
Nov 19, 2024, 15:14
Aaron Goodman: What is an "M protein"
Blog
Nov 19, 2024, 15:12
The ACS announced the inaugural Food is Medicine in Oncology Care Symposium
Blog
Nov 19, 2024, 15:08
Dinesh Pendharkar: Expanding access to Cancer Care to class of Healthcare Specialists from across the Globe
Blog
Nov 19, 2024, 15:00
NRG-GU010 is approaching the accrual target for the intensification cohort